Gram Research analysis of a 2026 mouse study found that boosting the LPLAT14 protein in the liver eased early liver stress during the first two weeks of a high-fat diet. Liver injury markers dropped, but the benefit disappeared by eight weeks, when fat buildup was severe.
According to research reviewed by Gram, a protein called LPLAT14 may help protect the liver during the early stages of damage from a high-fat diet. In a 2026 study published in FASEB BioAdvances, scientists increased this protein in the livers of mice fed a high-fat diet. The protein changed the types of fat in liver cell membranes, adding more oleic acid, a fat also found in olive oil, to a molecule called phosphatidylserine. After two weeks, the mice had lower blood levels of ALT, an enzyme that rises when the liver is stressed. By eight weeks, when heavy fat buildup had formed in the liver, this protective effect was gone. Body weight, blood sugar control, and overall liver fat did not change significantly. Because these results come from mice, they point toward ideas worth testing rather than proof of benefits for people.
Key Statistics
A 2026 mouse study published in FASEB BioAdvances found that boosting the LPLAT14 protein in the liver lowered blood levels of ALT, a marker of liver stress, after 2 weeks of high-fat feeding.
In that same 2026 study, the protective effect on liver stress was no longer seen at 8 weeks, when severe fat buildup had developed in the livers of the mice.
The 2026 mouse study reported that increasing LPLAT14 did not significantly change body weight, blood sugar control, or overall liver fat levels.
The Quick Take
- What they studied: Scientists asked whether boosting one liver protein, LPLAT14, could protect the liver from damage caused by a high-fat diet, and whether it could also help with weight, blood sugar, or fat buildup.
- Who participated: The study used laboratory mice fed a high-fat diet. The exact number of mice was not stated in the summary provided, and the results apply to animals, not people.
- Key finding: Increasing LPLAT14 in the liver led to lower blood levels of ALT, a marker of liver stress, after two weeks of high-fat feeding. This benefit did not appear at eight weeks, when heavy liver fat had built up. Weight, blood sugar control, and liver fat levels did not change significantly.
- What it means for you: This is early animal research and does not yet show that LPLAT14 protects human livers. It does suggest that fats inside liver cells may play a role in early liver stress, which is worth watching. Anyone concerned about fatty liver should talk with a doctor about diet, weight, alcohol use, and routine blood tests.
The Research Details
Researchers wanted to know what happens when the liver makes more of a protein called LPLAT14. This protein is an enzyme, a molecule that speeds up chemical reactions, and it helps build and rebuild fats in the thin outer layers of cells. Its role inside a living body has been poorly understood until now.
To test this, the team used mice that were fed a high-fat diet, a diet that commonly causes fatty liver changes in these animals. They delivered extra LPLAT14 directly to the liver using a modified virus, a common lab tool that carries genetic instructions into cells. The mice were then studied at two points: an early stage at two weeks and a later stage at eight weeks.
The researchers measured body weight, blood sugar control, and fat levels in the liver. They also used a method called lipidomics, which identifies and counts the many different fat molecules in tissue. Blood tests for liver enzymes, such as ALT, were used to check for liver stress or injury.
Studying mice lets scientists control the diet, timing, and genetics of each animal, which makes it easier to see cause and effect. Comparing an early stage with a later stage also shows whether a treatment works at one point in the disease but not another. In this case, the timing turned out to be important.
Using a gene-delivery virus to increase one protein in only the liver is a precise method. It helps show that the liver itself, rather than the whole body, is responsible for the effects seen. Lipidomics adds detail by showing exactly which fat molecules changed, not just whether total fat went up or down.
Still, these methods are not used in people. Results from this design show what might happen biologically, but they cannot confirm that the same steps would work in human patients.
The study was published in FASEB BioAdvances, a peer-reviewed journal, which means outside experts reviewed the work before publication. The researchers used a detailed fat-analysis method and tested two time points, which adds strength to the findings.
The summary does not report the number of mice used, which makes it harder to judge how strong the results are. Small animal studies can produce results that do not hold up in larger experiments. Readers should treat the findings as early evidence rather than settled science.
What the Results Show
The most notable result was a change in liver fats. When researchers increased LPLAT14, the liver contained significantly more phosphatidylserine molecules that carried oleic acid, a monounsaturated fat also found in olive oil. This suggests that the enzyme selectively places oleic acid into these fat molecules, which are important parts of cell membranes.
These changes appeared to have a protective effect early on. At two weeks of high-fat feeding, mice with extra LPLAT14 had significantly lower blood levels of ALT. ALT is an enzyme that leaks into the blood when liver cells are stressed or damaged, so lower levels suggest less early liver stress.
The benefit did not last. At eight weeks, when the mice had developed heavy fat buildup in the liver, the protective effect was not seen. This suggests that LPLAT14 may help during the early phase of fatty liver changes but cannot stop more advanced damage.
Importantly, LPLAT14 did not significantly change body weight, blood sugar control, or the amount of fat stored in the liver. This means the protein’s effect appears to be specific to certain fat molecules and early liver stress rather than a broad change in metabolism.
The researchers found that the increase in oleic acid-containing phosphatidylserine was the key change. This points to a possible mechanism, meaning a biological explanation for how the protein may help. Cell membranes need the right mix of fats to work well, and this study suggests that the type of fat built into those membranes matters.
The authors also suggested that the protection may come from helping cells cope with early stress. This idea is still a hypothesis, which means it is a possible explanation that needs further testing. The finding that the protein’s effect fades over time also suggests that timing is critical in how liver disease develops.
Fatty liver disease, now called metabolic dysfunction-associated steatotic liver disease (MASLD), is known to progress from simple fat buildup to more serious inflammation and scarring. Earlier research has linked changes in cell membrane fats to liver injury, and this study fits with that idea. Scientists have also studied the broader family of enzymes that rebuild membrane fats, but many members, including LPLAT14, have had little study in living animals.
This work adds to that picture by showing a specific effect in the liver during early high-fat feeding. It is consistent with the view that membrane fat balance matters in liver stress, though it is one of the first in vivo tests of LPLAT14 itself.
The study was done in mice, and mouse livers and metabolism do not work exactly like human ones. A treatment that helps mice may not help people in the same way, or at all.
The benefit was seen only at two weeks and disappeared by eight weeks. This means the protein does not appear to stop advanced liver disease, which is the stage most people are concerned about.
The method used a virus to deliver the protein, which is not a practical treatment for people. The summary also does not state the number of mice, so the reliability of the results is hard to judge. Finally, the study measured one liver enzyme as a sign of injury, and more detailed tests would be needed to confirm the level of damage.
The Bottom Line
Based on this single animal study, there is low confidence that LPLAT14 can protect human livers. The findings are interesting and suggest a possible target for future research, but no one should change medical care because of them. Confidence would increase only if human studies or repeated animal studies showed similar results. For general liver health, established steps such as maintaining a healthy weight, limiting alcohol, eating fewer ultra-processed foods, and getting regular movement remain well supported by existing research.
Researchers studying fatty liver disease, drug developers looking for new targets, and clinicians who follow emerging science may find this work relevant. People with fatty liver or risk factors for it may be curious, but they should not expect any change in care based on this study alone. People without liver concerns do not need to act on these findings yet.
Translating findings from mice into human treatments usually takes many years and several stages of testing. Even if LPLAT14 becomes a research target, safe and effective human treatments are unlikely to be available for a long time. Anyone with liver concerns should follow current medical guidance while this research develops.
Frequently Asked Questions
Can a liver protein protect against fatty liver disease?
Early research in mice suggests that the protein LPLAT14 may ease early liver stress caused by a high-fat diet. In a 2026 study, mice with extra LPLAT14 in their livers had lower ALT blood levels after two weeks. The effect did not appear at eight weeks, and no human trials have tested this yet.
What is LPLAT14 and what does it do in the body?
LPLAT14 is an enzyme that helps build and rebuild fat molecules in cell membranes, the protective outer layers of cells. In a 2026 mouse study, boosting it in the liver increased oleic acid, a monounsaturated fat also found in olive oil, within a membrane fat called phosphatidylserine.
How quickly does a high-fat diet affect the liver in mice?
In a 2026 mouse study, high-fat feeding caused mild liver stress within two weeks, measured by blood ALT levels. By eight weeks, heavy fat buildup had formed in the liver. The protective effect of LPLAT14 appeared only during the early stage, showing that timing matters in fatty liver research.
Is there a supplement or food that raises LPLAT14 in people?
No food or supplement has been proven to raise LPLAT14 in people. The mouse study used a virus to deliver extra protein directly to the liver, which is not a treatment option. Anyone concerned about fatty liver should talk with a doctor about diet, weight, alcohol use, and blood tests.
Want to Apply This Research?
- Track weekly body weight, waist measurements, and days per week with 150 minutes or more of moderate activity. If you have been told you have fatty liver, ask your doctor which liver blood tests, such as ALT, to monitor and how often, then log those results in the app.
- Use the app to set one small, measurable habit, such as swapping fried or heavily processed snacks for whole foods on at least five days per week. Log meals that are high in saturated or fried fats so you can see patterns over time. Remember that this app supports general healthy habits and does not replace medical advice.
- Review trends every four to eight weeks rather than daily, since liver and metabolic changes develop slowly. Combine app logs of diet, activity, and weight with periodic lab results from your doctor. Share summaries with your healthcare provider so they can judge whether changes are moving in the right direction.
This article summarizes an early study conducted in mice, and its results may not apply to people. It is not medical advice and should not be used to start, stop, or change any treatment, supplement, or diet. Anyone with concerns about fatty liver or liver health should consult a qualified healthcare provider for personal guidance and testing.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.